BIOGENES TECHNOLOGIES launches the world's first aptamer-based histochemistry staining product developed using its proprietary ...

To address this, Professor Jongmin Kim’s team developed the “START platform*1“ technology based on aptamers. Aptamers are ...

The EU has awarded the researchers €188,000 to support the project through September 2026, by which time they hope to have a validated prototype ready.

The clumps are thought to impair the function of neurons in the brain and spinal cord. Aptamers are already being used in cancer and Alzheimer’s diagnostics, and Gregory et al have adapted the ...

Pharmaceutics is the scientific discipline concerned with the process of creating the dosage form (such as a pill for oral administration or a powder for intravenous injection) of a therapeutic ...